Aim To determine whether intrathecal baclofen (ITB) therapy improves performance and performance satisfaction in goal areas identified by patients' parents. Method This study formed part of an ongoing multicentre national audit involving six paediatric ITB pump implant centres across Australia. The Canadian Occupational Performance Measure was the primary outcome measure utilized at baseline, 6 months, and 12 months after pump implants in paediatric patients receiving ITB therapy for the first time between 31st December 2009 and 31st December 2014. Results Twenty-five children had goals identified (mean age 11y 1mo), 19 had a diagnosis of cerebral palsy and 22 were at Gross Motor Function Classification System level IV, V, or equivalent. ...
Continuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has bee...
Among features of motor disorders in children, spasticity is associated with considerable morbidity ...
Objective: To investigate patients' expectations, met/unmet expectations and satisfaction with intra...
Purpose: To investigate the effects of intrathecal baclofen therapy (ITB) on health-related quality ...
PURPOSE: To assess attainment of individual treatment goals one year after intrathecal baclofen (ITB...
AIM: To investigate the effects of continuous intrathecal baclofen (ITB) therapy in children with ce...
Aim To investigate the effects of continuous intrathecal baclofen (ITB) therapy in children with cer...
Background: Intrathecal baclofen (ITB) is a useful treatment for hypertonia where non-invasive treat...
Introduction Increasing clinical use of Intrathecal baclofen (ITB) in Australian tertiary paediatric...
Objective: To investigate clinical efficacy and incidence of complications regarding intrathecal bac...
Background: Little is known about the long-term effects of Continuous intrathecal Baclofen (CITB) th...
Objective Intrathecal baclofen treatment is used for the treatment of dystonia in patients with seve...
Introduction: Intrathecal baclofen (ITB) treatment is applied in patients with spastic cerebral pals...
Continuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has bee...
Among features of motor disorders in children, spasticity is associated with considerable morbidity ...
Objective: To investigate patients' expectations, met/unmet expectations and satisfaction with intra...
Purpose: To investigate the effects of intrathecal baclofen therapy (ITB) on health-related quality ...
PURPOSE: To assess attainment of individual treatment goals one year after intrathecal baclofen (ITB...
AIM: To investigate the effects of continuous intrathecal baclofen (ITB) therapy in children with ce...
Aim To investigate the effects of continuous intrathecal baclofen (ITB) therapy in children with cer...
Background: Intrathecal baclofen (ITB) is a useful treatment for hypertonia where non-invasive treat...
Introduction Increasing clinical use of Intrathecal baclofen (ITB) in Australian tertiary paediatric...
Objective: To investigate clinical efficacy and incidence of complications regarding intrathecal bac...
Background: Little is known about the long-term effects of Continuous intrathecal Baclofen (CITB) th...
Objective Intrathecal baclofen treatment is used for the treatment of dystonia in patients with seve...
Introduction: Intrathecal baclofen (ITB) treatment is applied in patients with spastic cerebral pals...
Continuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has bee...
Among features of motor disorders in children, spasticity is associated with considerable morbidity ...
Objective: To investigate patients' expectations, met/unmet expectations and satisfaction with intra...